Advisor Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-22,768
Closed -$2.26M 662
2019
Q3
$2.26M Buy
22,768
+2,004
+10% +$190K 0.27% 76
2019
Q2
$1.92M Buy
20,764
+1,779
+9% +$169K 0.23% 83
2019
Q1
$1.79M Buy
18,985
+7,064
+59% +$618K 0.23% 84
2018
Q4
$764K Sell
11,921
-331
-3% -$24.4K 0.12% 187
2018
Q3
$1.1M Buy
12,252
+3,983
+48% +$352K 0.15% 136
2018
Q2
$657K Sell
8,269
-2,547
-24% -$211K 0.11% 209
2018
Q1
$965K Sell
10,816
-4,199
-28% -$403K 0.18% 126
2017
Q4
$1.54M Buy
15,015
+1,163
+8% +$131K 0.28% 78
2017
Q3
$2.02M Buy
13,852
+1,051
+8% +$143K 0.4% 49
2017
Q2
$1.66M Buy
12,801
+514
+4% +$63K 0.39% 56
2017
Q1
$1.53M Buy
12,287
+220
+2% +$26.3K 0.41% 53
2016
Q4
$1.4M Buy
12,067
+1,972
+20% +$220K 0.42% 55
2016
Q3
$1.05M Sell
10,095
-120
-1% -$13K 0.35% 73
2016
Q2
$1.01M Sell
10,215
-506
-5% -$52.3K 0.35% 76
2016
Q1
$1.07M Sell
10,721
-1,139
-10% -$117K 0.4% 64
2015
Q4
$1.42M Sell
11,860
-394
-3% -$45.6K 0.48% 57
2015
Q3
$1.33M Sell
12,254
-369
-3% -$45.8K 0.56% 44
2015
Q2
$1.46M Buy
12,623
+2,700
+27% +$309K 0.56% 45
2015
Q1
$1.14M Sell
9,923
-191
-2% -$22.8K 0.49% 53
2014
Q4
$1.13M Buy
10,114
+821
+9% +$86.6K 0.5% 52
2014
Q3
$881K Sell
9,293
-20
-0.2% -$1.8K 0.5% 53
2014
Q2
$800K Buy
9,313
+1,481
+19% +$113K 0.39% 71
2014
Q1
$547K Sell
7,832
-184
-2% -$14.6K 0.3% 109
2013
Q4
$677K Buy
8,016
+1,068
+15% +$84.5K 0.39% 82
2013
Q3
$536K Buy
6,948
+120
+2% +$8.41K 0.38% 88
2013
Q2
$399K Buy
+6,828
New +$411K 0.33% 103

Other funds holding CELG

Advisor Partners's CELG Position: Q4 2019 in Review

Advisor Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 22,768 shares — an estimated $2.26M sold.

Advisor Partners first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.26M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Advisor Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Advisor Partners sold 22,768 Celgene Corp shares in Q4 2019, an estimated $2.26M.
  • Advisor Partners first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Advisor Partners's Celgene Corp position peaked at $2.26M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Advisor Partners's 13F filing for Q4 2019, filed 24 Jan 2020.